Researchers have successfully targeted and eliminated breast cancer stem cells by blocking important enzymes in the glycolytic pathway, including hexokinase 2 (HK2), phosphofructokinase (PFK), and lactate dehydrogenase A (LDHA) [71]. The gene discussed is LDHA; the disease is breast carcinoma.